Our company locates in the revolutionary district which at the bank of Chishui river-- Gulin County, Sichuan Province. It is derived from --Sichuan Gulin Pharmaceutical Plant. It has more than over 300 workers and staff members and its annual output reaches 50 million Yuan. Our company is a modern pharmaceutical enterprise with scientific research, producing and selling patent medicine and Chinese traditional medicine, which is credited as a high-tech enterprise by Sichuan Scientific & Technological Bureau. Committed to the guidance of "human being first and serving the people", and the spirit of "unity, dedication, pragmatism, high efficiency, probity, and honesty", our company takes solving the sufferings of patients, digging the treasury of traditional medicine and vitalizing national pharmaceutical industry as our aim. After several years' development, our company has preliminarily become a collectivizing enterprise and possesses "Sichuan Longlife TCM Marketing Co., Ltd.","Gulin Chinese Herbal Medicine Research Institute" and "Longlife Medicine Materials Planting Base". The Research Institute mainly deals in developing new Chinese traditional medicine and pure plant medicine and now many projects are under research and development, among whom the update and substitute drug for Gansu Granule---- suspended release Granules (state Grade B new drug, first Chinese traditional patent suspended release medicine in China), has been listed in the "fifteenth" State Tackle Key Scientific Project; Sichuan Longlife TCM Marketing Co., Ltd. responsible for running Longlife Pharmacy; Longlife Medicine Materials Planting Base mainly responsible for planting Chinese herbal medicine like Ganhuang Grass and construction its production base according to GAP standard. About 7 dosage forms are produced, such as granules, tablets and capsules, etc. About 30 Chinese traditional patent medicines in nearly 40 specifications are produced. The production capability of Chinese herbal medicine has reached 1,000 tons per year, the productive capacity of Gansu Granule has reached 70,000 pieces per year, Chinese traditional patent tablets reached to 100 million tablets per year and Chinese traditional patent capsules reached to 100 million per year.
About 7 dosage forms are produced, such as granules, tablets and capsules, etc. About 30 Chinese traditional patent medicines in nearly 40 specifications are produced.